US Pharma Packaging Market - 展望与预测 2023-2028
- 市场报告
- ID: YPA266UA
- 交货时间: 1 工作日
- 标签: Pharma Packaging
市场概况
The US pharmaceutical packaging market had a valuation of $28.33 十亿 2022 并预计达到 $36.58 十亿 2028, 呈现复合年增长率 (复合年增长率) 的 4.35% 学习期间.
Pharmaceutical packaging plays a crucial role in the packaging process of pharmaceutical preparations. It includes tasks such as dosing, dispensing, and facilitating the use of pharmaceutical products. The primary objective of packaging is to ensure the safety and integrity of the drugs, with one important aspect being the selection of materials that do not react with the packaged drugs.
产品类别 | 市场报告 |
---|---|
数量. 页数 | 58 |
发布日期 | 可能 2023 |
基准年 | 2022 |
预测期 | 2023-2028 |
市场规模 | 美元 28.3 十亿 2021 |
细分市场 | Packaging Type, Primary Packaging Type, Material Type, End-user Type |
地区 | 我们 |
数量. 提及的公司数量 | 29 |
The market in the United States is experiencing significant growth, driven by factors such as the increasing demand for prescription drugs, the presence of leading pharmaceutical players, well-developed infrastructure, high investments in drug development, and a high per capita income. Among all the product groups in pharmaceutical packaging, parenteral containers have witnessed the fastest growth in demand. This can be attributed to advancements in biotechnology, which have led to the introduction of new injectable therapies.
市场细分
市场根据多种因素进行细分, including packaging type, primary packaging type, material type, and end-user type.
Segmentation by Packaging Type
Primary
Secondary
Tertiary
Segmentation by Primary Packaging Type
Ampoules
Vials
Blisters & Strip
瓶子 & Jars
Containers & Tubes
Pouches & Sachets
其他的
Segmentation by Material Type
纸
玻璃
Plastic
其他的
Segmentation by End-user Type
药品 & Biotech Companies
CMOs/CDMOs
其他的
在 2022, the United States held a significant market share in the North American pharmaceutical packaging market. This can be attributed to several factors, including the increasing demand for prescription drugs, the presence of leading pharmaceutical players, well-developed infrastructure, high investments in drug development, and high per capita income.
Within the US pharmaceutical packaging market, primary packaging accounted for over 70% 的市场份额. This is due to the growing demand for blister packs, 瓶子, vials, ampoules, pouches, 香袋, and bags, aligned with the increasing demand for pharmaceutical products.
Among primary packaging types, the strips and blister packaging segment accounted for a market share of 33.50% in the US pharmaceutical packaging market. This segment dominated others due to its extensive use as a crucial primary packaging component for pharmaceutical products.
In terms of material types, the paper segment holds a market share of 38.92% in the US pharmaceutical packaging market. This can be attributed to its high demand in secondary and tertiary packaging and the increasing need for recyclable materials.
Pharmaceutical and biotech companies accounted for the highest share of over 46% in the US pharmaceutical packaging market. This can be attributed to factors such as the growing aging population, increasing demand for branded drugs, over-the-counter drugs, and specialty medicines, patent expirations of drugs, and higher drug prices.
竞争格局
The market presents immense growth prospects for both current and future/emerging players due to advancements in the treatment of oncology, autoimmune diseases, diabetes, chronic illnesses, and rare diseases.
Key companies profiled in this report include Amcor, Aptar Group, Berry Global, Gerresheimers AG, WestRock Pharmaceuticals, ACG, Airnov, Becton, Dickinson and company (BD), Bilcare Research, Borosil, 覆铜板, Drug Plastics Group, DWK Life Sciences, LOG, Meghmani Group, Nolato, Nemera, PolyCine, Renolit, Specialty Polyfilms, Vetter, West Pharmaceuticals, Wihuri Group, Comar, Constantia, Kp, Nipro, Medical Packaging Inc, Bandall.